CurrentBlue Cross Blue Shield - OklahomaPolicy N/A

Specialty Drug Management List — Coverage Criteria

Defines the list of medications identified as specialty drugs by Blue Cross and Blue Shield of Oklahoma and explains coverage routing between pharmacy and medical benefits; intended for providers and members seeking coverage and benefit information.

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicySpecialty Drug Management List — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionObtain prior authorization when required using BCBSOK provider request forms or call the number on the member ID card.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

~170+drug entries (partial)

20+document chunks

2sections

855-710-6984assistance phone

Coverage Criteria

Listing a medication on the Specialty Drug Management List identifies it as a specialty drug for benefit-routing purposes but does not guarantee coverage. Inclusion on the list is informational; actual coverage depends on the member’s plan benefits and any applicable utilization management rules.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage for drugs shown on this list is subject to the member’s plan benefits and may require prior authorization or other plan-specific requirements before a drug can be considered for coverage. Providers should verify benefits and follow the payer’s authorization process (request forms or the phone number on the member ID card) and confirm whether the pharmacy or provider is in-network to avoid claim denials or reduced benefits.

This document segment presents a product listing and related administrative statements (e.g., route-of-administration keys and standard notices). No additional clinical coverage criteria, specific prior authorization rules, or billing codes are specified in this portion of the list.

Provider Actions and Authorization

Prior Authorization

Prior authorization may be required

Some listed specialty drugs may require prior authorization before coverage is considered. Providers should verify member benefit terms (including any step edits) and obtain any required approvals prior to dispensing or administration. Failure to obtain prior authorization when required or use of an out-of-network specialty pharmacy may result in claim denial or reduced benefits.

Prior authorization may be required for certain specialty medications — check member-specific benefits.
Using an out-of-network specialty pharmacy when an in-network specialty pharmacy is required can trigger denial or reduced benefits.
Listing on the Specialty Drug Management List does not guarantee coverage; approvals and other plan rules may apply.

Note

Prior authorization not specified in extract

This extract primarily provides a specialty drug list and product/route information and does not explicitly list detailed prior authorization rules, step therapy criteria, or affected billing codes for every product. Where authorization requirements are not specified here, refer to the member’s plan documents or contact the payer.

The list is informational and subject to change without notice.
No explicit step therapy rules are defined in this extract.
No detailed billing or CPT/HCPCS/NDC codes are provided in this segment.

Prior Authorization

Prior authorization requirement

Some drugs listed under either the pharmacy or medical benefit may have added plan-specific requirements (prior authorization, quantity limits, step edits) that must be met before coverage is approved. Providers should confirm whether a drug is covered under the pharmacy or medical benefit for the member and follow the corresponding authorization process.

Coverage may depend on whether the drug is dispensed via pharmacy benefit (often self-administered) or medical benefit (often provider-administered).
Certain oral oncology and hemophilia specialty drugs may have alternate in-network specialty pharmacy options for members.

Note

Prior authorization (not specified)

No specific prior authorization instructions or billing codes are provided in many portions of this document; providers must look up plan-specific requirements or use the payer’s provider resources for concrete submission instructions.

Portions of the document repeat contractor/relationship language without clinical authorization details.
When prior authorization steps are not specified in this list, use the payer contact resources described below.

Note

Prior authorization not specified in segment

This segment lists specialty drugs and administration routes but does not state explicit prior authorization conditions. Treat the list as informational; verify individual drug requirements on the payer’s authorization portal or by phone.

Route of Administration key is provided, but authorization triggers are not included here.
The list is subject to change without notice; product names are property of their owners.

Documentation Required

Provider documentation and submission

Providers must obtain and maintain any required documentation when requesting authorization. Use in-network specialty pharmacies when required by the member’s plan to avoid potential denials. Prime Therapeutics LLC is the contracted pharmacy solutions vendor — this relationship may affect pharmacy routing.

Provider request forms are available at bcbsok.com/provider (pharmacy) or bcbsil.com/provider (medical) as noted in the document.
Call the number on the member’s ID card for benefit and authorization questions or to locate an in-network specialty pharmacy.
Prime Therapeutics LLC is a separate contracted company; Blue Cross and Blue Shield of Oklahoma has an ownership interest — this may influence specialty pharmacy operations.

Documentation Required

No specific documentation or prior authorization instructions provided in listings

Many chunks in this extract are product listings with no additional documentation or prior authorization instructions. For those entries, providers should not assume coverage or authorization status and should proactively confirm requirements before treatment.

No specific documentation or prior authorization instructions are provided for individual products in these listings.
Do not assume a product listed equals covered without meeting plan-specific prior authorization rules.

Documentation Required

How to request authorization

How to request authorization: providers can locate request forms online and may call the number on the member’s ID card for plan-specific authorization criteria, pharmacy network assistance, or clinical questions.

Pharmacy benefit request forms: bcbsok.com/provider.
Medical benefit request forms referenced: bcbsil.com/provider (as listed in the document).
For member-specific questions or to find an in-network specialty pharmacy, call the number on the member’s ID card.

Note

Standard corporate and contractor relationship statements

This document includes standard corporate and contractor relationship statements but does not replace clinical policy guidance. Prime Therapeutics LLC is identified as a contracted pharmacy solutions vendor; the relationship is disclosed for transparency.

Relationship statements clarify contractor status between BCBSOK and specialty pharmacies.
Ownership interest in Prime Therapeutics is disclosed; operational details should be confirmed with the payer or contracted vendor.

Prior Authorization

The document indicates approvals may be needed

The source indicates approvals may be needed and that benefit terms (including step edits) depend on the member’s plan. Providers should verify whether step therapy applies for a given drug — this extract includes no step therapy rules and related guidance is absent.

The document explicitly notes that approvals or added requirements may be necessary based on plan benefits.
No step therapy rules are defined or listed in this extract; consult plan documents or the payer for step edits.

Step Therapy

No step therapy rules are defined in this extract

No step therapy rules are defined in this extract. For treatment sequencing or mandated trials of alternate therapies, check the member’s benefit plan or clinical policy documents.

This listing does not include step therapy entries or 'must-try' medication sequences.
If step therapy applies, it will be defined in the member’s detailed benefits or the payer’s clinical policy.

Note

None specified in this document segment

None specified in this document segment — the list is informational and many blocks repeat the subject-to-change and product ownership notices. Providers must not rely solely on this extract for authorization or coverage decisions.

Sections repeat route keys and subject-to-change notices without operational authorization guidance.
Contact the payer for any coverage determinations or prior authorization prerequisites.

Note

Not present in this partial document: no explicit authorization details

Not present in this partial document: no explicit authorization, prior authorization, or denial triggers are specified in several chunks — these are product listings only. Always confirm requirements with the payer before providing or dispensing specialty medications.

When no authorization language appears, treat the entry as informational and verify prior to treatment.
Use the contact methods referenced (ID-card phone number, provider web pages) to request authorization.

Definitions and Route Key

Specialty medication — definition

DefinitionMedication identified by the plan as treating complex and/or chronic conditions, often requiring special handling or storage.

Examples of conditionsMultiple sclerosis, hepatitis C, rheumatoid arthritis (illustrative examples in policy).

Benefit routingSelf‑administered specialty meds often covered under pharmacy benefit; provider‑administered meds often covered under medical benefit.

Coverage noteListing on the Specialty Drug Management List does not guarantee coverage; verify member benefits and prior authorization requirements.

Route of Administration key — abbreviations

COCombination

EXExternal

IJInjection

IMIntramuscular

INInhalation

IOIntraocular

ITIntrathecal

IVIntravenous

IXIntraarticular

IZIntravitreal

OPOphthalmic

OROral

SCSubcutaneous

Route of Administration key — full list

COCombination

EXExternal

IJInjection

IMIntramuscular

INInhalation

IOIntraocular

ITIntrathecal

IVIntravenous

IXIntraarticular

Route of Administration key — alternate references

COCombination

EXExternal

IJInjection

IMIntramuscular

INInhalation

IOIntraocular

ITIntrathecal

IVIntravenous

IXIntraarticular

Route of Administration key — repeated definition

COCombination

EXExternal

IJInjection

IMIntramuscular

INInhalation

IOIntraocular

ITIntrathecal

IVIntravenous

IXIntraarticular

Background

Specialty medications are typically used to treat complex or chronic conditions (for example, oncology, autoimmune, hematological, pulmonary, and enzyme deficiency disorders) and may require special handling or administration. Coverage routing often depends on the FDA‑approved route of administration: drugs approved for self‑administration are commonly covered under the pharmacy benefit, while drugs administered by a health care professional (for example, IV, IM, IS, IZ) are often covered under the medical benefit. Verify benefit type and site‑of‑care prior to ordering.

Step Therapy / Utilization Management

Requirement	Details
Benefit plan may apply step therapy or other utilization management
Providers should consult the member's benefit plan and use BCBSOK resources (request forms at bcbsok.com/provider or the phone number on the member ID card) for specific step-therapy or authorization requirements

Site of Care and Benefit Routing

Note

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicySpecialty Drug Management List — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionObtain prior authorization when required using BCBSOK provider request forms or call the number on the member ID card.

SourceLink

On This Page